CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. (Q46021334)
Jump to navigation
Jump to search
scientific article published in October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. |
scientific article published in October 2007 |
Statements
1 reference
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. (English)
1 reference
Sharon Nachman
1 reference
Edmund Capparelli
1 reference
Akihiko Saitoh
1 reference
Elizabeth Sarles
1 reference
Francesca Aweeka
1 reference
Andrea Kovacs
1 reference
Sandra K Burchett
1 reference
Andrew Wiznia
1 reference
Terence Fenton
1 reference
Stephen A Spector
1 reference
1 October 2007
1 reference
1 reference
21
1 reference
16
1 reference
2191-2199
1 reference